Floatz logo

Cyclophosphamide

Refractory Anemia

Fred Hutchinson Cancer CenterSmall moleculePhase 3Active
BB
69/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
56/ 100
Competitive Position
95/ 100

Competitive context

7 Active assets in the Refractory Anemia cohort.

Asset / SponsorPhaseRating
CYCLOSPORIN A
National Cancer Institute (NCI)
Phase 2BBB
Fludarabine
Fred Hutchinson Cancer Center
Phase 3BB
FILGRASTIM
National Cancer Institute (NCI)
Phase 3BB
METHOTREXATE
National Cancer Institute (NCI)
Phase 3BB
DEXAMETHASONE
National Cancer Institute (NCI)
Phase 3BB

View all 28 →

Same molecule, other indications

Cyclophosphamide is also rated in:

adult acute lymphoblastic leukemiaDormant
BBB
Indicative ·
79 / 100
View asset →
mycosis fungoidesDormant
BBB
Indicative ·
78 / 100
View asset →
B-cell childhood acute lymphoblastic leukemiaDormant
BBB
Indicative ·
78 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →